WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 71.10
-0.50 (-0.70%)
Oct 30, 2026, 1:21 PM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.23 billion as of October 30, 2026. It is the 25,056th most valuable company in the world and the 1,320th biggest in Taiwan. Its market cap has decreased by 3.66% in one year.
Market Cap
3.23B
Enterprise Value
4.02B
Revenue
1.21B
Global Rank
Country Rank
#1,320 Taiwan
PE Ratio
14.07
ChartMarket Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.23B, a decrease of -5.73%. That is a compound annual growth rate of -2.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 3.23B | -3.13% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hi-Clearance | 5.68B |
| Delta Asia International | 5.28B |
| Apex Biotechnology | 2.92B |
| Applied BioCode | 2.91B |
| Bonraybio | 2.65B |
| A Plus Biotechnology | 2.51B |
| Wellell | 2.36B |
| Dynamic Medical Technologies | 2.16B |